Genmab — April 2017
-
God morgen.

-
http://www.fiercepharma.com/marketing/j-j-partner-genmab-calls-it-quits-darzalex-non-hodgkin-s-lymphoma-trial : -A J&J spokesman added that "there will be potentially future programs to support Darzalex-based combination studies, in NHL patients, as investigator initiated studies."
-
-
Danske sælger.Er det mon medarbejderaktier?
-
Det var det jeg kunne huske.
-
Elendig timing.
-
enig Helge, worst timing ever!
-
Hvordan fungere dette her. Behøver de at sælge det hele på en gang?
-
Nej det gør de ikke. Han der exerviser warrents på kurs 66, behøver jo kun at sælge en lille del I markedet for at finansiere exercisen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind